首页> 美国卫生研究院文献>Pharmacy: Journal of Pharmacy Education and Practice >An Ethical Analysis of Pharmacy Benefit Manager (PBM) Practices
【2h】

An Ethical Analysis of Pharmacy Benefit Manager (PBM) Practices

机译:药房福利经理(PBM)行为的伦理分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The high costs associated with pharmaceuticals and the accompanying stakeholders are being closely evaluated in the search for solutions. As a major stakeholder in the U.S. pharmaceutical market, the practices of pharmacy benefit manager (PBM) organizations have been under increased scrutiny. Examples of controversial practices have included incentives driving formulary status and prohibiting pharmacists from disclosing information on lower-cost prescription alternatives. Ethical investigations have been largely omitted within the debate on the responsibilities of these organizations in the health care system. Ethical analysis of organizational practices is justified based on the potential impact during health care delivery. The objective of this study was to analyze several specific PBM practices using multiple ethical decision-making models to determine their ethical nature. This study systematically applied multiple ethical decision-making models and codes of ethics to a variety of practices associated with PBM-related dilemmas encountered in the pharmaceutical environment. The assessed scenarios resulted in mixed outcomes. PBM practices were both ethical and unethical depending on the applied ethical model. Despite variation across applied models, some practices were predominately ethical or unethical. The point of sale rebates were consistently determined as ethical, whereas market consolidation, gag clauses, and fluctuation of pharmacy reimbursements were all predominantly determined as unethical. The application of using provider codes of ethics created additional comparison and also contained mixed findings. This study provided a unique assessment of PBM practices and provides context from a variety of ethical perspectives. To the knowledge of the authors, these perspectives have not been previously applied to PBM practices in the literature. The application of ethical decision-making models offers a unique context to current health care dilemmas. It is important to analyze health care dilemmas using ethics-based frameworks to contribute solutions addressing complexities and values of all stakeholders in the health care environment.
机译:在寻找解决方案时,正在密切评估与药品及相关利益相关者相关的高成本。作为美国药品市场的主要利益相关者,药房福利经理(PBM)组织的做法受到了越来越多的审查。有争议的做法的例子包括激励措施提高配方地位,并禁止药剂师披露有关低成本处方药的信息。关于这些组织在卫生保健系统中的责任的辩论在很大程度上没有进行道德调查。根据医疗保健提供过程中的潜在影响,对组织做法进行伦理分析是合理的。这项研究的目的是使用多种道德决策模型来分析几种特定的PBM实践,以确定其道德性质。这项研究系统地将多种道德决策模型和道德规范应用于与制药环境中遇到的PBM相关困境相关的各种实践。评估的情景导致了不同的结果。取决于所应用的道德模型,PBM实践既是道德的又是不道德的。尽管应用模型之间存在差异,但某些实践还是道德或不道德的。始终将销售点返点确定为符合道德标准,而将市场整合,堵漏条款和药房费用波动视为主要不道德标准。使用提供者道德规范的应用产生了额外的比较,并且还包含不同的发现。这项研究对PBM的做法进行了独特的评估,并从各种道德角度提供了背景。据作者所知,这些观点以前尚未在文献中应用于PBM实践。道德决策模型的应用为当前的卫生保健难题提供了独特的背景。重要的是要使用基于道德的框架来分析医疗保健难题,以提供解决方案,以解决医疗保健环境中所有利益相关者的复杂性和价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号